Omalizumab Dose Step-Up and Treatment Response in Patients with Chronic Idiopathic/Spontaneous Urticaria (CIU/CSU): Results from the OPTIMA Study. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 2, n. S1, p. S52, 2018. DOI: 10.25251/skin.2.supp.52. Disponível em: https://skin.dermsquared.com/skin/article/view/295. Acesso em: 19 apr. 2025.